JAZZ - Jazz Pharma sale of Epidiolex or spin out of CNS makese sense - analyst
2023-10-20 13:48:29 ET
More on Jazz Pharmaceuticals
- Jazz Pharma: Playing The High Notes With Xywav
- Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript
- Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential
- Biggest stock movers today: Hewlett Packard Enterprise, Intuitive Surgical and more
- Jazz Pharmaceuticals exploring strategic options, including sale - Bloomberg (update)
For further details see:
Jazz Pharma sale of Epidiolex or spin out of CNS makese sense - analyst